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Carbon monoxide (CO)-releasing molecules (CO-RMs) are intensively studied to provide
cytoprotective and anti-inflammatory effects of CO in inflammatory conditions including
intestinal inflammation. The water-soluble CORM-A1 reduced apoptosis and NADPH
oxidase (NOX)-derived reactive oxygen species (ROS) induced by tumor necrosis factor
(TNF)-α/cycloheximide (CHX) in mouse MODE-K intestinal epithelial cells (IECs), without
influencing TNF-α/CHX-induced mitochondrial superoxide anion (O•−2 ). The aim of the
present study in the same model was to comparatively investigate the influence of
lipid-soluble CORM-2 and water-soluble CORM-401, shown in vitro to release more
CO under oxidative conditions. CORM-2 abolished TNF-α/CHX-induced total cellular
ROS whereas CORM-401 partially reduced it, both partially reducing TNF-α/CHX-
induced cell death. Only CORM-2 increased mitochondrial O•−2 production after 2 h
of incubation. CORM-2 reduced TNF-α/CHX-, rotenone- and antimycin-A-induced
mitochondrial O•−2 production; CORM-401 only reduced the effect of antimycin-A.
Co-treatment with CORM-401 during 1 h exposure to H2O2 reduced H2O2 (7.5 mM)-
induced ROS production and cell death, whereas CORM-2 did not. The study illustrates
the importance of the chemical characteristics of different CO-RMs. The lipid solubility
of CORM-2 might contribute to its interference with TNF-α/CHX-induced mitochondrial
ROS signaling, at least in mouse IECs. CORM-401 is more effective than other CO-RMs
under H2O2-induced oxidative stress conditions.
Keywords: carbon monoxide-releasing molecules, hydrogen peroxide, intestinal epithelial cells, mitochondria,
oxidative stress, reactive oxygen species, solubility, TNF-α/CHX
INTRODUCTION
Acute and chronic gastrointestinal (GI) inflammatory disease conditions are associated with
persistent oxidative stress originating from increased reactive oxygen species (ROS) that are
known to initiate and perpetuate inflammation (Bhattacharyya et al., 2014; Mittal et al., 2014).
Oxidative stress-induced epithelial cell damage and increased intestinal permeability toward
luminal commensal bacterial material, which activates mucosal immune cells and triggers muscular
inflammation, can contribute to the severity of acute GI disorders as observed in animal models
of septic ileus, necrotizing enterocolitis and ischemia/reperfusion injury (Anup et al., 1999;
de Winter et al., 2005; Baregamian et al., 2009; De Backer et al., 2009; Guan et al., 2009).
Excessive production of ROS and mucosal injury has also been reported in animal models of
inflammatory bowel disease (IBD) (Ahn et al., 2001; Reifen et al., 2004; Cetinkaya et al., 2005)
and in colonic tissue of patients with ulcerative colitis (Oshitani et al., 1993; Nishikawa et al., 2005).
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Tumor necrosis factor (TNF)-α is one of the early inflammatory
mediators thought to play an important role in epithelial barrier
dysfunction by inducing intestinal epithelial cell (IEC) apoptosis.
ROS play an important role in TNF-α-induced apoptotic cell
death of IECs (Jin et al., 2008; Baregamian et al., 2009; Babu
et al., 2012). The nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase (NOX) family and the mitochondrial electron
transport chain (ETC) are the two major ROS-producing sources
involved in TNF-α/cycloheximide (CHX)-induced cell death in
rat IEC-6 cells (Jin et al., 2008) and in mouse MODE-K cells
(Babu et al., 2015b). In MODE-K cells in particular, complexes
I and II of the mitochondrial ETC were found to be the main
sites of superoxide anion (O•−2 ) production in addition to NOX
(Babu et al., 2015b). As the endogenous antioxidant defense
system does not seem sufficient to counteract TNF-α-induced
ROS production, neutralizing excessive ROS production might
be an effective therapeutic strategy to reduce intestinal barrier
dysfunction during GI inflammation.
The stress-responsive protein heme oxygenase (HO)-1 is up-
regulated by oxidative stress and inflammatory signals, and
it generates biliverdin, a powerful antioxidant, and carbon
monoxide (CO), which exerts antioxidant, anti-inflammatory
and cytoprotective effects (Ryter et al., 2006; Motterlini and
Otterbein, 2010). Inhalation of CO gas has been successfully
applied in animal models of inflammation and oxidative
stress but translation to humans might be difficult (Ji et al.,
2016). From pharmacological and therapeutic perspectives, small
molecules capable of delivering controlled amounts of CO to
biological systems have therefore been developed to mimic
the intrinsic beneficial effects of CO (Motterlini et al., 2002;
Sawle et al., 2005; Motterlini and Otterbein, 2010). These
compounds, known as CO-releasing molecules (CO-RMs), have
been extensively studied and belong to two major classes: (1)
metal carbonyl complexes containing ruthenium, manganese, or
molybdenum, which carry CO bound to the transition metal
and (2) boranocarbonates, which do not contain transition
metals but the metalloid boron and release CO spontaneously
in physiological conditions, the rate of release being affected
by changes in pH. While the original lipophilic CO-RMs such
as CORM-1 ([Mn2(CO)10]) and CORM-2 ([Ru(CO)3Cl2]2)
have to be dissolved in organic solvents such as dimethyl
sulfoxide (DMSO) (Motterlini et al., 2002), water-soluble CO-
RMs such as CORM-3 ([Ru(CO)3Cl(glycinate)]) and CORM-
A1 (Na2[H3BCO2]) were subsequently developed (Clark et al.,
2003; Motterlini et al., 2005b). These compounds have been
shown to be pharmacologically active in limiting cellular and
tissue dysfunctions in a number of pathological disorders
associated with inflammation and tissue injury (Motterlini and
Foresti, 2014). The inhibitory effect of CO and CO-RMs on
cytokine-induced changes in the intestinal epithelium might also
contribute to their beneficial effect in acute GI inflammation
such as postoperative ileus (Babu et al., 2015c) and in chronic
GI inflammation such as IBD (Takagi et al., 2015). Although
the exact mechanism(s) for the antioxidant and cytoprotective
effect of CO is (are) still under investigation, emerging evidence
indicates that the beneficial properties of CO may be linked
to its ability to bind to hemoproteins, such as NOX and
mitochondrial complexes in different tissues (Taille et al., 2005;
Bilban et al., 2008). At the mitochondrial level, CO was shown
to induce a transient burst of mitochondrial ROS (O•−2 ) that
is thought to promote a preconditioning state, enabling it
to counteract subsequent oxidative stress (Taille et al., 2005;
Chin et al., 2007; Vieira et al., 2008). We previously showed
that the water-soluble CORM-A1 reduced both TNF-α/CHX-
induced ROS production and apoptosis in MODE-K IECs
(Babu et al., 2012, 2015a). At cytoprotective concentrations,
CORM-A1 per se did not induce mitochondrial O•−2 ; however,
CORM-A1 inhibited NOX-derived ROS production, but not
mitochondrial O•−2 production, after challenging MODE-K
IECs with TNF-α (Babu et al., 2015a). This absence of an
effect at the mitochondrial level might be related to the
water-soluble properties of this CO-RM, which prevent its
penetration to sites of ROS production in mitochondria. By
contrast, the lipophilic CORM-2 was shown to induce ROS
production from mitochondria in human bronchial smooth
muscle cells (Taille et al., 2005). The cytoprotective properties
of CORM-2 in IECs and its effect on cellular targets mediating
ROS production have yet to be investigated. CORM-401
[Mn(CO)4{S2CNMe(CH2CO2H)}] is a recently developed water-
soluble CO-RM that releases up to three equivalents of CO
per mole of compound, in contrast to CORM-A1 which
releases one equivalent of CO (Motterlini et al., 2005a; Crook
et al., 2011; Fayad-Kobeissi et al., 2016). Moreover, the rate
of CO release from CORM-401 in cell-free in vitro systems
is accelerated in the presence of biologically relevant oxidants,
such as hydrogen peroxide (H2O2) (Fayad-Kobeissi et al.,
2016).
In view of the above considerations, in the present study, we
compared the cytoprotective effects of CORM-2 and CORM-401
in MODE-K IECs under oxidative stress conditions, evaluating
their effects on oxidant-generating system(s). For the protocol
with a high concentration of H2O2, also CORM-A1 was
compared as this was not investigated in our previous study with
the compound (Babu et al., 2015a). The major characteristics of
the three CO-RMs are summarized in Table 1.
MATERIALS AND METHODS
Chemicals and Reagents
Reagents for cell culture, including Dulbecco’s modified Eagle’s
medium (DMEM), fetal bovine serum, penicillin/streptomycin
and GlutaMAX were obtained from Gibco BRL
(Grand Island, NY, USA). Carboxylated analog of
2′7′-dichlorodihydrofluorescein diacetate acetyl ester (carboxy-
H2DCFDA), MitoTracker Deep Red FM, MitoTracker
Green FM, MitoSOX Red, Sytox Green, Sytox Red and
tetramethylrhodamine methyl ester (TMRM) were purchased
from Molecular Probes – Invitrogen (Carlsbad, CA, USA).
Recombinant murine TNF-α was purchased from R&D systems
(Minneapolis, MN, USA). Antimycin-A, CHX, CORM-2,
DMSO, H2O2 and rotenone were purchased from Sigma (St.
Louis, MO, USA). CORM-A1 and CORM-401 were synthesized
as previously described (Motterlini et al., 2005b; Crook et al.,
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TABLE 1 | Structure and characteristics of CO-RMs studied.
Compound Chemical structure Solubility In vitro half-life (min) at
t = 37◦C, pH = 7.4




DMSO t1/2 ≈ 1 min (Motterlini et al.,





H2O t1/2 < 4 min (Crook et al.,
2011); t1/2 ≈ 15 min








2011). Stock solutions of CORM-2 were prepared in DMSO,
whereas CORM-401 was dissolved in phosphate buffered
saline (PBS); the solutions were both protected from light in
all experiments. Inactive CORM-2 (iCORM-2) was prepared
by keeping the stock solution in DMSO for 18 h at 37◦C
in a 5% CO2 humidified atmosphere to liberate CO (Sun
et al., 2008). As CORM-401 solutions as such are stable, no
iCORM-401 comparable to iCORM-2 can be prepared. Fayad-
Kobeissi et al. (2016) used a mixture of equimolar amounts of
Na2CNMeCO2Na.nH2O and MnSO4 as a surrogate iCORM-401
as these compounds compose the skeletal basis of the CORM-401
molecule without CO; this mixture did not reproduce the effects
of CORM-401 in the in vitro models of vascular relaxation and
angiogenesis studied. H2O2, obtained in a liquid formulation,
was dissolved in culture medium. All other chemicals were
dissolved in DMSO, except TNF-α, which was dissolved in PBS.
Cell Culture
The mouse small IEC line, MODE-K (a generous gift from
Dr. Ingo B. Autenrieth, University of Tübingen, Germany)
was used in our study. This cell line was derived from
the duodenum-jejunum from normal young C3H/HeJ mouse
immortalized by simian virus (SV)-40 large T gene transfer.
The cells are undifferentiated but still exhibit morphological and
phenotypic characteristics of normal enterocytes (Vidal et al.,
1993). MODE-K cells (passage 10–35) were cultured in DMEM
medium supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, and 5% penicillin (10,000 units/ml) with streptomycin
(10 mg/ml). Cultures were maintained in a humidified 5% CO2
atmosphere at 37◦C, and experiments were conducted on cells at
approximately 80–90% confluence. MODE-K cells were seeded in
culture medium containing 10% serum, grown for 36 h, and then
serum-starved overnight. Cells were seeded at either 1× 104 cells
per 200 µL of culture medium per well in a 96-well microtiter
plate (for cell viability assay) or 2.5× 105 cells per 2 mL of culture
medium per well in a six-well plate (for all other assays).
Treatment Protocols
At 48 h after seeding, MODE-K cells were exposed to oxidative
stress by treatment with 1 ng/ml TNF-α plus 10 µg/ml CHX
for 6 h, 1 mM H2O2 for 40 min, 7.5 mM H2O2 for 1 h,
7.5 µM rotenone for 6 h, or 10 µM antimycin-A for 6 h. To
study the influence of CORM-2 and CORM-401 vs. the oxidant
stimuli, CO-RMs were pre-incubated from 1 h before exposure
to the oxidative stress stimulus, followed by co-incubation
of CO-RMs with the stimulus. However, for the experiments
involving 7.5 mM H2O2 for 1 h, CORM-2 and CORM-401 were
also just pre-incubated for 1 h or only co-incubated for 1 h;
CORM-A1 was also studied vs. 7.5 mM H2O2, as this was not
performed in the previous study on CORM-A1 (Babu et al.,
2015a).
CORM-2 and CORM-401 were used at 40 and 50 µM,
respectively, as these were the highest concentrations without an
effect per se on cell viability of MODE-K cells when incubated
for 12 h (n = 3 for each compound, data not shown). CORM-A1
was studied at 100 µM, as determined earlier with the same assay
(Babu et al., 2012, 2015a).
Determination of Cell Viability
Cell viability was assessed by luminescent cell viability assay
with CellTiter-Glo (Promega, Madison, WI, USA) according to
the manufacturer’s protocol. This assay determines the number
of viable cells in culture based on quantitation of ATP, an
indicator of metabolically active cells. Briefly, MODE-K cells
were plated into 96-well plates and treated as described under
cell culture. At the end of the incubation period for 12 h
with CO-RMs on day 3, an equal volume of the luminescent
substrate and lysis buffer mix from the assay kit was added.
The mixture was transferred to an opaque 96-well plate,
and luminescence was recorded using a GloMax Microplate
Luminometer (Promega). The index of cellular viability was
calculated as the percentage of luminescence with respect to
untreated control cells.
Simultaneous Determination of
Intracellular Total ROS Generation and
Cell Death
ROS production and cell death were measured simultaneously
by flow cytometry, allowing measurement of ROS production in
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gated viable cells. Carboxy-H2DCFDA is a cell-permeable ROS
indicator that is non-fluorescent until the acetate groups are
removed by intracellular esterases and oxidation occurs within
the cell. When oxidized by various active oxygen species, it
is irreversibly converted to the fluorescent form, DCF. The
fluorescence generated by DCF is proportional to the rate of
carboxy-H2DCFDA oxidation, which is in turn indicative of the
cellular oxidizing activity and intracellular ROS levels. The cells
were loaded in the dark with 10 µM carboxy-H2DCFDA for
40 min before the end of the treatment period with a given
oxidant stimulus. The floating and adherent cells were collected
by trypsinization and washed twice with HBSS with calcium and
magnesium. Sytox Red (2.5 nM) dead cell stain was added to the
cell suspension, and simultaneous detection of ROS production
and cell death was performed in a single experimental setup
by flow cytometry using 488 nm excitation wavelength with
530/30 nm (FL1; DCF) and 670/30 (FL4; Sytox Red) emission
filters. Viable (Sytox Red-negative) cells were gated, and the
green fluorescence of the ROS probe was analyzed in these
cells.
Simultaneous Determination of
Mitochondrial O•−2 Anion and Cell Death
MitoSOX Red was used to detect mitochondrial O•−2 production.
This modified cationic dihydroethidium dye localizes to the
mitochondria where it is oxidized by O•−2 to generate bright
red fluorescence (Robinson et al., 2006). Mitochondrial O•−2
generation and cell death were determined in a single
experimental setup by treating the cell samples with MitoSOX
Red and Sytox Red. The cells were loaded in the dark with 5 µM
MitoSOX Red for 30 min before the end of the treatment period
with a given oxidant stimulus, collected, washed twice with HBSS,
and then stained with 2.5 nM Sytox Red. The samples were
run on a flow cytometer with 488 nm excitation to measure
oxidized MitoSOX Red in the FL2 channel and Sytox Red in
the FL4 channel. Cell debris with low FSC (forward scatter)
and SSC (side scatter) was excluded from the analysis. The
mean fluorescence intensity (MFI) of MitoSOX Red staining
was analyzed in the gated viable cell population (Sytox Red-
negative). Thus, MitoSOX Red of the cells analyzed excluded any
non-specific interference from dead cells.
For all experiments with analysis of ROS, (a) the fluorescence
properties of at least 30,000 cells were acquired from each sample;
(b) the samples were analyzed immediately after ending the
incubation with the ROS indicator and strictly protected from
light; (c) basal ROS generation in cells not exposed to TNF-
α/CHX, H2O2, rotenone or antimycin-A, in culture medium
alone or in medium containing the solvent of the drug to be
studied vs. the oxidative stress stimulus, was used as a control;
and (d) the MFIs of treated samples were expressed as percentage
of the control MFI (set as 100%).
Measurement of Mitochondrial
Dysfunction
Determination of respiratory chain damage was performed
by double staining with two different mitochondria-specific
dyes, MitoTracker Green FM and MitoTracker Deep Red FM,
to distinguish total and respiring mitochondria, respectively.
Mitochondria in cells stained with MitoTracker Green FM
dye exhibit bright green fluorescein-like fluorescence (FL1;
fluorescence emission at 516 nm) as this dye accumulates
in the lipid environment of mitochondria regardless of 9m
and becomes fluorescent. MitoTracker Deep Red FM does
not fluoresce until it enters an actively respiring cell, where
it is oxidized to the corresponding red fluorescence probe
(FL4; fluorescence emission at 665 nm) that then sequesters
in the mitochondria in proportion to 9m (Cottet-Rousselle
et al., 2011; Tang et al., 2011). So, MitoTracker Green will
stain all mitochondria while MitoTracker Deep Red FM will
stain active respiring mitochondria. The treated cells were
incubated with 200 nM MitoTracker Green FM and 25 nM
MitoTracker Deep Red FM in the dark at 37◦C for 30 min
before the end of the treatment period. Next, the cells were
harvested and the pellets were suspended in 0.5 mL of PBS.
The samples were analyzed immediately by flow cytometry. The
percentage of MitoTracker Green-positive/MitoTracker Deep
Red-negative cells is an important parameter of accumulation
of cells with non-respiring (dysfunctional) mitochondria (Zhou
et al., 2011).
Simultaneous Determination of
Mitochondrial Membrane Potential (9m)
and Cell Death
Determination of the changes in mitochondrial membrane
potential (9m) was performed using TMRM along with
staining of Sytox Green (for cell death). TMRM is a cell-
permeant, lipophilic cationic, red–orange fluorescent dye that is
readily sequestered by active mitochondria. TMRM is a single
wavelength dye that can be combined with a cell death marker
to measure fluorescence exclusively in the viable cells. Briefly,
following the treatment, the cells were washed twice with HBSS
and then incubated with 200 nM TMRM solution prepared
in DMEM medium for 30 min. Subsequently, the cells were
washed twice with HBSS and stained with 2 nM Sytox Green
prior to measurement. The percentage of TMRM and Sytox
Green stained cells was calculated from at least 30,000 cells of
each sample in comparison to the control. TMRM was excited
at 488 nm, and fluorescence emitted at 588 nm (FL2) was
measured in gated viable (Sytox Green-negative) cells by flow
cytometry.
For assays of ROS, mitochondrial dysfunction and 9m, the
samples were acquired using a BD LSR II flow cytometer and
analyzed using FACSDiva software (BD Biosciences, San Jose,
CA, USA).
Statistical Analysis
All data are expressed as the mean ± SEM. The comparison of
the means was performed using Student’s t-test for two groups of
data and ANOVA followed by Bonferroni’s multiple comparison
test for comparison of more than two groups. Differences were
considered significant at P < 0.05.
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FIGURE 1 | Effects of CORM-2 (A,B) or CORM-401 (C,D) on TNF-α/CHX-induced intracellular total ROS production and cell death in MODE-K cells. MODE-K cells
were treated for 6 h with TNF-α (1 ng/ml) plus CHX (10 µg/ml) in the absence or presence of CORM-2 (40 µM) or CORM-401 (50 µM), added 1 h before TNF-α/CHX.
Intracellular total ROS levels are assessed with carboxy-H2DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels were
expressed as % of control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of
CORM-2 or CORM-401 per se was also tested. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone.
RESULTS
Effects of CORM-2 and CORM-401 on
TNF-α/CHX-Induced Changes in
Intracellular Total ROS Production and
Cell Death
To determine whether CORM-2 and CORM-401 could modulate
ROS production and exert cytoprotection during inflammatory
conditions, TNF-α/CHX-induced intracellular total ROS
production and cell death were simultaneously measured by flow
cytometry. Treatment of MODE-K cells with TNF-α/CHX for
6 h increased total ROS by approximately 200% (Figures 1A,C)
and induced approximately 50% cell death (Figures 1B,D).
Treatment of MODE-K cells with CORM-2 per se was without
effect, but CORM-2 abolished TNF-α/CHX-induced ROS
production (Figure 1A) with a significant reduction of cell
death (Figure 1B); iCORM-2 had no effect per se nor did it
influence the TNF-α/CHX-induced changes (data not shown).
CORM-401 per se did not affect basal total ROS production and
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cell survival. Treatment of cells with CORM-401 significantly
reduced both TNF-α/CHX-induced ROS production and cell
death (Figures 1C,D).
Effects of CORM-2 and CORM-401 on
H2O2-Induced Changes in Intracellular
Total ROS Production
The capacity of CORM-2 and CORM-401 to modulate oxidant-
generating system(s) was further investigated in vitro using
the model of H2O2-induced oxidative stress in MODE-K cells.
First, incubation of cells with 1 mM H2O2 for 40 min was
studied, as this condition was previously shown to induce a
level of intracellular total ROS production relatively similar to
that induced by TNF-α/CHX treatment for 6 h, albeit without
inducing cell death (Babu et al., 2015b). H2O2 increased ROS
production by 430–505% compared with control (Figures 2A,C)
indeed without inducing cell death (Figures 2B,D). Both CORM-
2 and CORM-401 significantly attenuated the H2O2-induced
increase in total ROS production (Figures 2A,C).
As the release of CO from CORM-401 has been shown
to be accelerated by increasing concentrations of oxidants, a
concentration-response curve to H2O2 higher than 1 mM was
constructed, assessing both intracellular total ROS production
and cell death (Figures 2E,F). From these experiments,
incubation of cells with 7.5 mM H2O2 for 1 h was selected as this
condition induced a level of cell death similar to that induced by
TNF-α/CHX for 6 h, i.e., 57± 4% (Figure 2F); this concentration
of H2O2 increased ROS production by 2900% relative to the
control (Figure 2E).
When the standard treatment protocol was used for CORM-
2 (i.e., pre-treatment for 1 h before exposure to H2O2 and
then co-treatment during exposure to H2O2), H2O2-induced
ROS production and cell death were significantly reduced by
34 ± 10% and 41 ± 4%, respectively (n = 3; Figures 3A,B).
By contrast, either pre-treatment with CORM-2 for 1 h or co-
treatment with CORM-2 during the 1 h exposure to H2O2 did not
affect H2O2-induced ROS production (Figure 3A) or cell death
(Figure 3B). Pre-treatment of cells with CORM-401 followed
by co-treatment with CORM-401 and H2O2 was even more
effective as it decreased both H2O2-induced ROS production
and cell death by 75 ± 5% and 72 ± 6%, respectively (n = 3;
Figures 3C,D). Interestingly, and in contrast to the observations
made with CORM-2, just pre-treating cells with CORM-401
for 1 h or just co-treating them with CORM-401 during the
1 h exposure to H2O2 was sufficient to significantly reduce
H2O2-induced ROS production and cell death, although to a
lesser extent compared with the pre- plus co-treatment protocol
(n = 3; Figures 3C,D). Another water-soluble CO-RM, CORM-
A1 showed similar effects as CORM-2 (n= 3; Figures 3E,F).
Effects of CORM-2 and CORM-401 on
TNF-α/CHX-Induced Changes in
Mitochondrial O•−2 Production and Cell
Death
The influence of CORM-2 and CORM-401 on TNF-α/CHX-
induced mitochondrial O•−2 production was assessed by using
the fluorescent probe MitoSOX Red in conjunction with Sytox
Red, to discriminate viable vs. dead cells, in a single experimental
setup. Exposure of cells to TNF-α/CHX increased mitochondrial
O•−2 production by approximately 200% relative to the control,
and treatment with CORM-2 reduced this effect (Figure 4A)
alongside a concomitant decrease in TNF-α/CHX-induced cell
death (Figure 4B). iCORM-2 had no effect per se nor did it
influence the TNF-α/CHX-induced changes (data not shown).
By contrast, although CORM-401 significantly reduced TNF-
α/CHX-induced cell death (Figure 4D), it did not influence TNF-
α/CHX-induced mitochondrial O•−2 production (Figure 4C).
Incubated for 7 h, neither CORM-2 nor CORM-401 per se
increased mitochondrial O•−2 production (Figures 4A,C). When
treating the cells for 1, 2, or 3 h, CORM-2 promoted a significant
increase in mitochondrial O•−2 when incubated for 2 h, whereas
CORM-401 did not change mitochondrial O•−2 production
(Figure 4E); also iCORM-2 was without effect (data not shown).
Treatment with CORM-2 or CORM-401 did not result in an
increase in intracellular total ROS production at these time points
(Figure 4F).
Effects of CORM-2 and CORM-401 on
Mitochondrial Complex I- and Complex
III-Induced Changes in Mitochondrial
O•−2 and Cell Death
Rotenone (7.5 µM), an inhibitor of mitochondrial complex I,
induced an increase in mitochondrial O•−2 level comparable to
that induced by TNF-α/CHX (Figures 5A,C), without affecting
cell survival (Figures 5B,D). The concentration of 7.5 µM
rotenone was selected based on a concentration-response study
of the effect of rotenone on mitochondrial O•−2 , when incubated
for 6 h to mimic the exposure time to TNF-α/CHX (Babu et al.,
2015a). Treatment with CORM-2 nearly abolished rotenone-
induced mitochondrial O•−2 production, whereas CORM-401
had no effect (Figures 5A,C).
The influence of CORM-2 and CORM-401 on mitochondrial
O•−2 production at the level of mitochondrial complex III was
investigated by use of the complex III inhibitor antimycin-A,
an agent well known to induce O•−2 production at this site.
Antimycin-A was used at 10 µM for 6 h (Babu et al., 2015a)
as this concentration did not induce cell death in MODE-
K cells (see Figures 5F,H), but increased mitochondrial O•−2
production to a level comparable to that induced by TNF-α/CHX
(see Figures 5E,G). Both CORM-2 and CORM-401 significantly
decreased (Figures 5E,G) antimycin-A-induced mitochondrial
O•−2 production.
iCORM-2 had no influence on the rotenone- or antimycin-A-
induced increase in mitochondrial O•−2 levels (data not shown).
Effects of CORM-2 and CORM-401 on
TNF-α/CHX-Induced Changes in
Mitochondrial Dysfunction and
Mitochondrial Membrane Potential (9m)
of MODE-K Cells
Double staining of MODE-K cells with two different
mitochondria-specific dyes to distinguish actively respiring
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FIGURE 2 | (A–D) Effects of CORM-2 (A,B) or CORM-401 (C,D) on H2O2-induced intracellular total ROS production and cell death in MODE-K cells. MODE-K cells
were treated for 40 min with H2O2 (1 mM) in the absence or presence of CORM-2 (40 µM) or CORM-401 (50 µM), added 1 h before H2O2. Intracellular total ROS
levels were assessed with carboxy-H2DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels are expressed as % of
control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401
per se was also tested. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. H2O2 alone. (E,F) Influence of H2O2 on intracellular
total ROS production and cell death, measured as described for (A–D). MODE-K cells were treated for 1 h with 2.5–10 mM H2O2. Control cells were incubated with
serum-free medium alone. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control.
Frontiers in Pharmacology | www.frontiersin.org 7 February 2017 | Volume 8 | Article 31
fphar-08-00031 February 6, 2017 Time: 12:2 # 8
Babu et al. CO-RMs under Oxidative Stress Conditions
FIGURE 3 | Effects of CORM-2 (A,B), CORM-401 (C,D) or CORM-A1 (E,F) on H2O2-induced intracellular total ROS production and cell death in MODE-K cells.
MODE-K cells were treated for 1 h with H2O2 (7.5 mM); CORM-2 (40 µM), CORM-401 (50 µM) or CORM-A1 (100 µM) was either pre-incubated for 1 h and then
co-incubated with H2O2 for 1 h (vertical striped bars), only pre-incubated for 1 h (horizontal striped bars) or co-incubated with H2O2 for 1 h (transverse striped bars).
Intracellular total ROS levels were assessed with carboxy-H2DCFDA (DCF), and gated on the viable, Sytox Red-negative population. Intracellular total ROS levels are
expressed as % of control DCF MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of
CORM-2, CORM-401 or CORM-A1 per se was also tested. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. H2O2 alone.
(MitoTracker Deep Red FM-positive) and total (MitoTracker
Green FM-positive) mitochondria revealed an increase in
the number of respiration-interrupted mitochondria in the
P2-gated region upon treatment of cells with TNF-α/CHX
(representative examples in the third panel of Figures 6A,C)
compared with untreated control cells (35–40% vs. 4–6%;
Figures 6B,D). Treatment with CORM-2 (Figures 6A,B)
significantly attenuated the TNF-α/CHX-induced increase in
dysfunctional mitochondria, whereas treatment with CORM-401
did not have any effect on this parameter (Figures 6C,D).
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FIGURE 4 | (A–D) Effects of CORM-2 (A,B) or CORM-401 (C,D) on TNF-α/CHX-induced mitochondrial O•−2 production and cell death in MODE-K cells. MODE-K
cells were treated for 6 h with TNF-α (1 ng/ml) plus CHX (10 µg/ml) in the absence or presence of CORM-2 (40 µM) or CORM-401 (50 µM), added 1 h before
TNF-α/CHX. Mitochondrial O•−2 levels were assessed with MitoSOX Red, and gated on the viable, Sytox Red-negative population. Mitochondrial O
•−
2 levels are
expressed as % of control MitoSOX Red MFI; cell death is expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the
effect of CORM-2 or CORM-401 per se was also tested. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone.
(E,F) Influence of CORM-2 (40 µM) or CORM-401 (50 µM) per se, incubated for 1–3 h, on levels of mitochondrial O•−2 (E), measured as described for (A–D), and
intracellular total ROS (F), measured as described in Figure 1. Mean ± SEM of three independent experiments. ∗P < 0.05 vs. untreated control at the given time
point.
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FIGURE 5 | Effects of CORM-2 or CORM-401 on mitochondrial complex I (rotenone; Rot; A–D)- and mitochondrial complex III (antimycin-A; Ant-A; E–H)-induced
mitochondrial O•−2 production and cell death in MODE-K cells. MODE-K cells were treated for 6 h with rotenone (7.5 µM) or antimycin-A (10 µM) in the absence or
presence of CORM-2 (40 µM; A,B,E,F) or CORM-401 (50 µM; C,D,G,H), added 1 h before rotenone or antimycin-A. Mitochondrial O•−2 levels were assessed with
MitoSOX Red, and gated on the viable, Sytox Red-negative population. Mitochondrial O•−2 levels are expressed as % of control MitoSOX Red MFI; cell death is
expressed as % Sytox Red positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 per se was also tested.
Mean ± SEM of three independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. rotenone or antimycin-A alone.
Frontiers in Pharmacology | www.frontiersin.org 10 February 2017 | Volume 8 | Article 31
fphar-08-00031 February 6, 2017 Time: 12:2 # 11
Babu et al. CO-RMs under Oxidative Stress Conditions
FIGURE 6 | Effects of CORM-2 (A,B) or CORM-401 (C,D) on TNF-α/CHX-induced mitochondrial dysfunction in MODE-K cells. MODE-K cells were treated for 6 h
with TNF-α (1 ng/ml)/CHX (10 µg/ml), in the absence and presence of CORM-2 (40 µM) or CORM-401 (50 µM), added 1 h before TNF-α/CHX. The number of cells
with respiring mitochondria was assessed with MitoTracker Green FM (FL1; FITC) and MitoTracker Deep Red FM (FL4; APC). Control cells were incubated with
serum-free medium alone; the effect of CORM-2 or CORM-401 per se was also tested. (A,C) Representative dot plots of the flow cytometric analysis showing the
effect of CORM-2 (A) or CORM-401 (C) on MitoTracker Green FM (total mitochondria) vs. MitoTracker Deep Red FM (actively respiring mitochondria) fluorescence of
viable cells after treatment with TNF-α/CHX. Cells in the gated region (P2) contain respiration-interrupted mitochondria. (B,D) Quantification of flow cytometric
measurements (expressed as % of cells with dysfunctional mitochondria) for experiments with CORM-2 (B) and CORM-401 (D). Mean ± SEM of three independent
experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone.
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FIGURE 7 | Effects of CORM-2 (A,B) or CORM-401 (C,D) on TNF-α/CHX-induced changes in mitochondrial membrane potential and cell death in MODE-K cells.
MODE-K cells were treated for 6 h with TNF-α (1 ng/ml)/CHX (10 µg/ml), incubated for 6 h, in the absence and presence of CORM-2 (40 µM) or CORM-401
(50 µM), added 1 h before TNF-α/CHX. Mitochondrial membrane potential was assessed with TMRM, and gated on the viable, Sytox Green-negative population.
Mitochondrial membrane potential is expressed as % of cells with depolarized mitochondria as measured by TMRM staining; cell death is expressed as % Sytox
Green positivity. Control cells were incubated with serum-free medium alone; the effect of CORM-2 or CORM-401 per se was also tested. Mean ± SEM of three
independent experiments. ∗P < 0.05 vs. control. #P < 0.05 vs. TNF-α/CHX alone.
We next studied the influence of CORM-2 and CORM-
401 on TNF-α/CHX-induced changes in 9m using a
potentiometric dye, TMRM. TMRM facilitates analysis of
cell death simultaneously in combination with the cell death
marker Sytox Green. Approximately 7–8% of control cells
showed depolarized mitochondria. Treatment of cells with
TNF-α/CHX caused approximately 60% depolarization of
mitochondria (Figures 7A,C). CORM-2 decreased the number
of depolarized cells by TNF-α/CHX to 39% (Figure 7A) but
CORM-401 did not influence this parameter (Figure 7C),
whereas their inhibitory effect on TNF-α/CHX-induced cell
death was confirmed (Figures 7B,D).
iCORM-2 had no influence on the TNF-α/CHX-induced
changes in both assays (data not shown).
DISCUSSION
TNF-α/CHX-induced apoptosis of MODE-K cells is associated
with a marked production of ROS, the major sources being
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NOX and mitochondrial ETC complexes I and II (Babu et al.,
2012, 2015b). One of the possible cellular mechanisms by
which CO confers cytoprotection is via modulation of ROS
production (Peers et al., 2015). We previously found that water-
soluble CORM-A1 reduces TNF-α/CHX-induced apoptosis by
inhibiting NOX-derived ROS production but not mitochondrial
O•−2 production induced by TNF-α (Babu et al., 2012, 2015a);
treatment of MODE-K cells with CORM-A1 at concentrations
that display a cytoprotective effect did not change basal
mitochondrial O•−2 production, even in the first hours after its
administration. These results suggest that CORM-A1 is unable
to interfere with sites of ROS production at the mitochondrial
level; this result might be attributed to the water-soluble property
of this CO-RM impairing its penetration into the cell and/or
through the inner mitochondrial membrane (Horton et al.,
2008). In the present study, we investigated the influence of
the lipid-soluble CORM-2 under oxidative stress conditions in
comparison with the newly developed water-soluble CORM-
401, which was shown to release more equivalents of CO under
oxidant conditions (Fayad-Kobeissi et al., 2016); see Table 2A for
a qualitative summary of the effects of CORM-2 and CORM-
401 in basal conditions and vs. TNF-α/CHX, rotenone, and
antimycin-A treatment.
Mechanism of Action of CORM-2 during
TNF-α/CHX-Induced Oxidative Stress
In contrast to previous results with CORM-A1 (Babu et al.,
2015a), pre- and co-incubation of MODE-K cells with CORM-2
abolished TNF-α/CHX-induced total cellular ROS production
and markedly diminished cell death. CORM-2 also reduced
TNF-α/CHX-induced mitochondrial O•−2 production suggesting
that CO released from CORM-2 can interfere at mitochondrial
ROS production sites. CORM-2 indeed also reduced rotenone
and antimycin-A-induced mitochondrial O•−2 production
demonstrating its capacity to mitigate complex I and complex
III-derived ROS. The observed effects of CORM-2 can be
attributed to the effect of CO released from it, as iCORM-2 both
per se and in the presence of the stimuli (TNF-α/CHX, rotenone
and antimycin-A) had no effect. Heme-containing proteins in
mitochondria (cytochromes) and NOX enzymes in the cells are
considered the major targets of CO due to the high affinity of CO
for heme (Foresti and Motterlini, 2010). At the mitochondrial
level, CO is known to inhibit complex IV (cytochrome c oxidase),
the terminal enzyme within the ETC, resulting in a significant
transient burst of mitochondria-derived ROS (O•−2 ). Several
reports support that a partial inhibition of complex IV may
create a preconditioning state to protect cells against subsequent
oxidative insults (Chin et al., 2007; Zuckerbraun et al., 2007;
Kim et al., 2008). CORM-2 per se increased mitochondrial
O•−2 levels temporarily at 2 h of its incubation in MODE-K
cells, whereas the total cellular ROS level measured at the same
time point did not show any increase; the intracellular ROS
detecting probe carboxy-H2DCFDA can indeed be oxidized by
ROS types, such as H2O2 and hydroxyl radical but not O•−2
(Myhre et al., 2003). The early mitochondrial O•−2 induction by
CORM-2 might contribute to its cytoprotective effect against
TNF-α/CHX treatment. The induction of mitochondrial O•−2
production by CORM-2 per se and the reduction by CORM-2 of
mitochondrial O•−2 produced upon TNF-α/CHX, rotenone and
antimycin-A treatment might be related to its lipid solubility. It
seems plausible that the hydrophobic surface of CORM-2 enables
its easy penetration through the outer and inner mitochondrial
membrane, thus releasing CO inside the matrix. CORM-2
increased mitochondria-derived ROS as early as 30 min after
its incubation with human airway smooth muscle cells (Taille
et al., 2005). In MODE-K cells, measurable mitochondrial O•−2
was observed only after 2 h incubation, but this does not exclude
the induction of mitochondrial O•−2 by CORM-2 before 2 h.
We have previously identified that significant ROS production
by TNF-α in MODE-K cells can only be observed from 2 h on,
in contrast to other IECs, indicating that MODE-K cells are
able to counteract the initial burst of oxidative stress up to this
time point, after which the antioxidant defense can no longer
be maintained (Babu et al., 2015b). The results of the current
study therefore suggest a role of the lipid-soluble nature of
CORM-2 in interfering with mitochondrial ROS signaling in
MODE-K IECs; further studies in other cell types are warranted
to corroborate this phenomenon. Superoxide anion produced
from NOX is converted into H2O2 by superoxide dismutase
(SOD)-1 (Cu/ZnSOD) in the cytoplasm, whereas O•−2 produced
from mitochondria are either released as such into the cytoplasm
by voltage-dependent anion channels (VDACs) or first converted
into H2O2 by SOD-2 (MnSOD)/SOD-1 before diffusing across
the mitochondrial membrane into the cytoplasm (Han et al.,
2003a). CORM-2 only partially reduced TNF-α/CHX-induced
mitochondrial O•−2 production, so that some mitochondrial O
•−
2
/H2O2 theoretically might leak into the cytoplasm in MODE-K
cells. However, at least H2O2 should then contribute to the ROS
signal picked up with carboxy-H2DCFDA and this part should
not be influenced by treatment with CORM-2, as originating
from mitochondrial O•−2 not suppressed with CORM-2. As the
increase in the DCF signal by TNF-α/CHX was fully abolished
by CORM-2, this mitochondrial leakage does not seem to occur
in MODE-K cells; this result further illustrates that CORM-2
abolishes NOX-derived ROS in MODE-K cells.
Mechanism of Action of CORM-401
during TNF-α/CHX-Induced Oxidative
Stress
Similar to CORM-A1, CORM-401 reduced TNF-α/CHX-
induced total cellular ROS production and cell death without
any influence on TNF-α/CHX-induced mitochondrial O•−2
production. Notably, CORM-401 per se did not have any effect
on mitochondrial O•−2 production. CORM-A1 attenuated the
decrease in 9m and the increase in mitochondrial dysfunction
by TNF-α/CHX, which might be related to its inhibitory effect
on mitochondrial respiration (Babu et al., 2015a). By contrast,
CORM-401 did not influence these mitochondrial effects
mediated by TNF-α. The inability of CORM-401 to modulate
TNF-α/CHX-induced mitochondrial O•−2 production and other
mitochondrial parameters seems to exclude mitochondria as
a possible target influenced by CORM-401 during TNF-α/
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TABLE 2A | Qualitative summary of the effects of CORM-2 and CORM-401, incubated for 7 h, in basal conditions and vs. TNF-α/CHX, rotenone and
antimycin-A treatment.
TNF-α/CHX Rotenone Antimycin-A




Mitochondrial O•−2 Mitochondrial O
•−
2
Probes Carboxy- MitoSOX MitoTracker Green/ TMRM MitoSOX Red MitoSOX Red
H2DCFDA Red MitoTracker Deep Red
CORM-2 Basal = = = = = =
Oxidant
stimulus
CORM-401 Basal = = = = = =
Oxidant
stimulus = = = =
=, Not influenced; , Reduced; , Abolished.
TABLE 2B | Qualitative summary of the effects of CORM-2, CORM-401 and CORM-A1 vs. H2O2 treatment (1 mM for 40 min and 7.5 mM for 1 h).
H2O2
Parameter-Probe Total ROS - Carboxy-H2DCFDA
Concentration of stimulus 1 mM H2O2 7.5 mM H2O2
Period of incubation 40 min 1 h
Pre- +
Co-incubation




=, Not influenced; , Reduced; , From Babu et al. (2015a).
CHX-induced cell death. Complexes I and II of the ETC are
the major mitochondrial ROS production sites during TNF-
α/CHX-induced cell death in MODE-K cells (Babu et al., 2015b).
Consistent with the observation that CORM-401 does not
influence TNF-α/CHX-induced mitochondrial O•−2 , CORM-401
was not able to reduce mitochondrial O•−2 production by the
complex I inhibitor rotenone. This result is probably related to
the fact that rotenone-induced mitochondrial O•−2 is released
into the mitochondrial matrix (Chen et al., 2003; Rodriguez-
Rocha et al., 2013). Indeed, as reported for CORM-A1 (Babu
et al., 2015a), CORM-401 was able to reduce antimycin-A-
induced mitochondrial O•−2 generation. This result could be
attributed to the fact that the mitochondrial O•−2 generated by
the Qi site inhibitor of complex III antimycin-A is reported to
be fully (St-Pierre et al., 2002) or at least partially (Han et al.,
2003b) released into the mitochondrial intermembrane space.
Still, we have previously observed that myxothiazole, an inhibitor
of complex III at the Qo site, partially reduced TNF-α/CHX-
induced total ROS and cell death in MODE-K cells (Babu et al.,
2015b), implying that part of TNF-α/CHX-induced ROS must
also be released into the mitochondrial intermembrane space.
The lack of any effect of CORM-401 vs. TNF-α/CHX-induced
mitochondrial ROS might be related to near full use of CORM-
401-derived CO in the cytoplasm to counteract NOX-derived
ROS upon exposure to TNF-α. As NOX enzymes are not activated
by antimycin-A, a higher amount of CO from CORM-401 might
reach the mitochondrial intermembrane space upon exposure of
MODE-K cells to antimycin-A, resulting in a more pronounced
reduction of mitochondrial O•−2 than observed with CORM-2
treatment. As CORM-401 does not interfere with TNF-α/CHX-
induced mitochondrial ROS, its inhibitory action on total cellular
ROS induced by TNF-α/CHX treatment is exclusively related to
inhibition of ROS derived from NOX, the second major source
of TNF-α/CHX-induced ROS production. Inhibition of NOX by
CO leading to decreased cytoplasmic O•−2 production has been
previously reported (Bilban et al., 2006; Srisook et al., 2006; Wang
et al., 2007; Kelsen et al., 2008).
Differential Effects of CORM-2,
CORM-A1 and CORM-401 during
H2O2-Induced Cytotoxic Oxidative Stress
The main cellular ROS involved in redox signaling is probably
H2O2, as O•−2 produced by various intracellular sources is either
spontaneously or through SODs dismutated into H2O2. H2O2
is the most abundant ROS in cells; it is relatively stable and
less toxic than other types of ROS and capable of diffusing
across membranes (Bienert et al., 2006). Physiologically, low
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endogenous levels of H2O2 function as signaling molecules for
the regulation of eukaryotic signal transduction but endogenous
overproduction of H2O2 is implicated in pathophysiological
oxidative stress (Van de Bittner et al., 2010). Similarly, exogenous
addition of higher concentrations of H2O2 leads to oxidative
stress and apoptotic cell death (Veal et al., 2007). The degree
of effect of CORM-2 and CORM-401 under oxidative stress
conditions in comparison with CORM-A1 was therefore also
investigated vs. H2O2-induced ROS in MODE-K cells (see
Table 2B for a qualitative summary of the effects of CORM-2,
CORM-401, and CORM-A1 vs. H2O2). Incubation of MODE-K
cells with CORM-2 or CORM-401 from 1 h before and during
exposure to a non-cytotoxic concentration of H2O2 (1 mM)
for 40 min similarly reduced H2O2-induced intracellular total
ROS levels, which is comparable to our earlier observation with
CORM-A1 (Babu et al., 2015a). However, when tested vs. 7.5 mM
H2O2 for 1 h, inducing a similar level of cell death as TNF-
α/CHX, but a much higher degree of total ROS, differences were
observed for CORM-401 vs. CORM-2 and CORM-A1. CORM-
401 is a water-soluble CO-RM with a half-life of CO release of 12-
14 min; it is able to release up to three CO per mole of compound,
whereas CORM-2 and CORM-A1 release one CO per mole of
compound. Moreover, the release of CO is increased over time
in the presence of biologically relevant oxidants, such as H2O2
(Fayad-Kobeissi et al., 2016). This acceleration of CO release from
CORM-401 when more oxidants are present probably explains
why CORM-401 is active in the presence of 7.5 mM H2O2 when
co-incubating the cells with the compound only during the 1 h
exposure to H2O2; the high degree of oxidative stress imposed by
7.5 mM H2O2 can be expected to maximally accelerate CO release
from CORM-401. This effect does not occur with CORM-2 and
CORM-A1, which were ineffective with this treatment protocol.
Surprisingly, CORM-401 was also mildly effective when only pre-
incubated for 1 h before exposure of the cells to 7.5 mM H2O2.
There is not a high ROS level in MODE-K cells before exposure
to 7.5 mM H2O2; thus, CO release from CORM-401 is not
accelerated. Still, the amount of CO released from CORM-401
seems sufficient to provide some protection to the cells against
7.5 mM H2O2 after washout of CORM-401. We do not have a
definitive explanation for this observation, which did not occur
with CORM-2 and CORM-A1. Both these compounds were only
effective vs. 7.5 mM H2O2 upon 1 h pre-incubation plus 1 h
co-incubation. As no real iCORM-401 can be prepared, some
influence of the scaffold of CORM-401 cannot fully be excluded.
CONCLUSION
CORM-2 and CORM-401 show differential cytoprotective effects
under oxidative stress conditions in MODE-K IECs. Both
CORM-2 and CORM-401 show antioxidant and cytoprotective
effects under oxidative stress associated with inflammation (TNF-
α/CHX). The cytoprotective effect of CORM-401 mitigates NOX-
derived ROS, whereas CORM-2 interferes with both NOX and
mitochondria-derived ROS to protect MODE-K cells from TNF-
α/CHX-induced cell death; the mitochondrial effect of CORM-
2 might be related to its lipophilicity. CORM-401 was more
effective than CORM-2 in protecting cells against oxidative stress
and cell death, induced by a high concentration of exogenous
H2O2. This result might be related to the ability of CORM-401
to release more CO under oxidative conditions, suggesting that
this compound may be effective under conditions of persistent
oxidative stress such as in the case of acute and chronic
GI disorders. Once probes are available allowing to analyze
the subcellular location of released CO, it will be possible to
investigate whether CO released from different CO-RMs can
show a different subcellular trajectory.
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